![]() |
시장보고서
상품코드
1384827
세계의 고압산소요법 기기 시장 규모, 점유율, 산업 동향 분석 리포트 : 용도별, 제품별, 지역별 전망과 예측(2023-2030년)Global Hyperbaric Oxygen Therapy Devices Market Size, Share & Industry Trends Analysis Report By Application, By Product, By Regional Outlook and Forecast, 2023 - 2030 |
고압산소요법 기기 시장 규모는 예측 기간 중 CAGR 5.1%로 성장하며, 2030년에는 47억 달러에 달할 것으로 예측됩니다. 2022년 시장 규모는 1,13,114대로, 성장률은 4.9%에 달하고 있습니다.(2019-2022년)
그러나, 압력 변화로 인한 상처는 압력 변화로 인한 상처를 의미하며, HBOT 중 압력 변화는 귀, 부비동, 폐에 영향을 미칠 수 있습니다. 환자는 귀 통증, 부비동 혼잡, 폐 손상을 경험할 수 있습니다. 이러한 위험을 줄이기 위해 환자를 신중하게 선별하고 안전 조치를 취하지만, 일부 환자는 압력 외상 가능성 때문에 HBOT를 받지 않으려는 사람도 있습니다. 고농도 산소에 장시간 노출되면 산소 중독을 일으켜 폐와 중추신경계 문제를 유발할 수 있으며, HBOT 세션은 산소 중독의 위험을 최소화하기 위해 주의 깊게 모니터링됩니다. 경우에 따라 건강 보험이 HBOT를 보장하지 않을 수 있으며, 자기 부담금을 지불할 수 없는 환자들은 HBOT를 이용하기 어렵고, HBOT와 그 위험에 대한 잘못된 정보와 오해가 잠재적인 환자들의 발목을 잡을 수도 있습니다. 위의 측면은 시장 성장에 방해가 될 수 있습니다.
COVID-19는 고압산소치료기 시장에 부정적인 영향을 미쳤습니다. 다른 많은 산업과 마찬가지로 전염병의 초기 단계에서 HBOT 장비를 포함한 의료기기의 제조 및 공급망은 혼란을 겪었습니다. 잠금, 이동 제한 및 공급망 중단은 이러한 장비의 생산 및 유통에 영향을 미쳤습니다. 이로 인해 당장 생명을 위협하는 것으로 간주되지 않는 증상에 대한 HBOT 기기의 사용이 일시적으로 감소했으며, COVID-19 관련 합병증 치료에 대한 HBOT의 효능을 탐구하는 임상시험과 연구가 시작되었습니다. 그러나 시장은 팬데믹 이후 빠르게 회복되어 향후 수년간 크게 확대될 것으로 예상됩니다.
용도별 전망
용도에 따라 시장은 상처 치유, 감압증, 감염 치료, 가스 색전증 및 기타로 세분화됩니다. 감압증 분야는 2022년 시장에서 큰 매출 점유율을 차지할 것으로 예상되며, HBOT는 '잠수병'으로도 알려진 감압증(DCS)에 대한 매우 효과적인 치료법입니다. 감압증은 스쿠버 다이버나 수중 작업자가 고압 환경(수중 등)에서 저압 환경(수면)으로 너무 빠르게 상승할 때 발생합니다. 이 급격한 압력 변화로 인해 체내 조직과 혈류에 질소 기포가 발생하여 관절통, 흉통, 호흡곤란, 신경증상 등 다양한 증상을 유발합니다.
제품 전망
제품별로는 모노플레이스, 멀티플레이스, 국소형 등으로 구분되며, 2022년에는 모노플레이스 부문이 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 모노플레이스 시스템은 사용이 편리하고 병원에 최소한의 가스 공급이 필요하기 때문에 채택률이 높고 상업적 활용도가 높아 시장 점유율 확대의 주요 요인으로 작용하고 있습니다. 가장 널리 사용되는 고압챔버는 ETC의 BARA-MED, BARA-MEDXD, BARA-MED Select, Pan-America Hyperbarics, Inc.의 PAH-S1-3800 고압챔버와 PAH-S1 고압챔버가 있습니다.
지역별 전망
지역별로는 북미, 유럽, 아시아태평양, LAMEA로 시장을 분석했으며, 2022년에는 북미가 시장에서 가장 높은 매출 점유율을 기록할 것으로 예상됩니다. 이 지역의 인구 증가로 인해 고압 산소 치료에 대한 수요와 상처 회복 치료의 필요성이 증가하고 있습니다. 2023년 2월, 미국 마우이 메모리얼 메디컬 센터는 치유되지 않는 상처에 대한 종합적인 접근 방식을 제공하는 고압 산소 치료를 갖춘 상처 치료 클리닉을 개설했습니다.를 개설했습니다.
The Global Hyperbaric Oxygen Therapy Devices Market size is expected to reach $4.7 billion by 2030, rising at a market growth of 5.1% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,13,114 units, experiencing a growth of 4.9% (2019-2022).
HBOT can be used as an adjunctive treatment for certain infections, particularly those caused by anaerobic bacteria or those that benefit from increased oxygen levels to enhance the body's natural defense mechanisms. Consequently, the infection treatment segment experienced $351.9 million revenue in the market in 2022. Anaerobic bacteria are microorganisms that thrive in low-oxygen environments. HBOT exposes the body to high oxygen concentrations, creating an oxygen-rich environment inhospitable to many anaerobic pathogens. This inhibits the growth and replication of these bacteria. HBOT is administered in specialized hyperbaric chambers under the supervision of trained medical personnel. Some of the factors impacting the market are growing demand for next generation multiplace chambers, rising prevalence of chronic diseases and side effects and complications associated with HBOT.
Next generation multiplace chambers are designed with a focus on patient comfort. They often offer more spacious interiors with better seating arrangements, lighting, and entertainment options. Enhanced comfort can encourage patients to undergo longer and more effective HBOT sessions. Multiplace chambers can accommodate multiple patients simultaneously, making them a more cost-effective and efficient option for healthcare facilities. This increased capacity can reduce waiting times for patients and improve accessibility to HBOT therapy. The rising number of chronic diseases has significantly driven the hyperbaric oxygen therapy devices market growth. Chronic diseases are long-term medical conditions that often require ongoing treatment and care. HBOT has proven effective in managing and treating various chronic diseases and associated complications, increasing adoption. Diabetes is an ordinary chronic disease that can lead to difficulties such as diabetic foot ulcers. HBOT is a recognized treatment for diabetic foot ulcers, as it promotes wound healing and reduces the risk of amputation. Therefore, as healthcare providers and patients recognize the advantages of HBOT in managing and improving the quality of life for those with chronic diseases, the market for hyperbaric oxygen therapy devices is expected to continue to rise.
However, Barotrauma refers to wounds caused by changes in pressure. During HBOT, changes in pressure can affect the ears, sinuses, and lungs. Patients may experience ear pain, sinus congestion, or lung injuries. In order to mitigate this risk, patients are carefully screened, and safety measures are put in place, but the potential for barotrauma can deter some individuals from seeking HBOT. Prolonged exposure to high oxygen levels can lead to oxygen toxicity, which can cause lung and central nervous system problems. HBOT sessions are carefully monitored to minimize the risk of oxygen toxicity. In some circumstances, health insurance may not cover HBOT, making it less accessible to patients who cannot afford the out-of-pocket costs. Misinformation or misconceptions about HBOT and its risks can deter potential patients. The abovementioned aspects will hamper the market growth.
COVID-19 had a negative impact on the hyperbaric oxygen therapy devices market. Like many other industries, the manufacturing and supply chain for medical devices, including HBOT devices, were disrupted during the early stages of the pandemic. Lockdowns, restrictions on movement, and supply chain interruptions affected the production and distribution of these devices. This led to a temporary decline in the use of HBOT devices for conditions that were not considered immediately life-threatening. Clinical trials and studies exploring the efficacy of HBOT in treating COVID-19-related complications were initiated. However, the market witnessed a speedy recovery after the pandemic and will expand significantly in the coming years.
Application Outlook
Based on application, the market is fragmented into wound healing, decompression sickness, infection treatment, gas embolism, and others. The decompression sickness segment garnered a significant revenue share in the market in 2022. HBOT is a highly effective treatment for decompression sickness (DCS), also known as "the bends." DCS occurs when a scuba diver or underwater worker ascends too quickly from a high-pressure environment (such as underwater) to a lower-pressure environment (the surface). This rapid change in pressure can cause nitrogen bubbles in the body's tissues and bloodstream, leading to various symptoms, including joint pain, chest pain, breathing difficulties, and neurological symptoms.
Product Outlook
On the basis of product, the market is segmented into monoplace, multiplace, and topical. In 2022, the monoplace segment dominated the market with the maximum revenue share. The substantial adoption rate and commercial accessibility of monoplace systems, due to their user-friendliness and minimal need for hospital gas supply, are significant contributors to its larger market share. The most popular hyperbaric chambers are BARA-MED, BARA-MEDXD, and BARA-MED Select by ETC; PAH-S1-3800 Hyperbaric Chamber and PAH-S1 Hyperbaric Chamber by Pan-America Hyperbarics, Inc.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region registered the highest revenue share in the market. The region's growing population has fueled the region's demand for hyperbaric oxygen therapy and the need for wound recovery treatment. Consumers' increasing disposable income has prompted them to seek technologically advanced medical treatments and therapies. In February of 2023, the Maui Memorial Medical Center in the United States opened a wound care clinic with hyperbaric oxygen therapy, which provides a comprehensive approach to non-healing wounds.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fink Engineering Pty Ltd, Environmental Tectonics Corporation, HAUX-LIFE-SUPPORT GmbH, Gulf Coast Hyperbarics, Inc., HearMEC Co., Ltd., Hyperbaric SAC, Sechrist Industries, Inc, SOS Group GBR Ltd., Perry Baromedical Corporation and SMP Ltd.
Market Segments covered in the Report:
By Application (Volume, Unit, USD Million, 2019-30)
By Product (Volume, Unit, USD Million, 2019-30)
By Geography (Volume, Unit, USD Million, 2019-30)
Companies Profiled
Unique Offerings from KBV Research